Literature DB >> 15696565

Disease activity measurement of rheumatoid arthritis: Comparison of the simplified disease activity index (SDAI) and the disease activity score including 28 joints (DAS28) in daily routine.

Burkhard F Leeb1, Ingrid Andel, Judith Sautner, Mirela Bogdan, Adil Maktari, Thomas Nothnagl, Bernhard Rintelen.   

Abstract

OBJECTIVE: To assess the reliability and congruency of the Simplified Disease Activity Index (SDAI) compared with the Disease Activity Score including 28 joints (DAS28) in daily practice.
METHODS: In 399 consecutive rheumatoid arthritis patients (307 women, 92 men), the SDAI and the DAS28 were calculated. Additionally, 115 of them were observed for 1 year and changes of both values were recorded. Joint assessments were performed by 4 experienced physicians. DAS28 and SDAI values and the respective changes were compared by correlation and regression analyses. Reliability assessment and factor analyses were performed. Disease activity categorizing was compared by the Wilcoxon's rank sum test.
RESULTS: The median +/- SD scores were 3.42 +/- 1.45 for the DAS28 and 11.50 +/- 11.50 for the SDAI. Spearman's rho was 0.897 (P < 0.0001). Score changes were also significantly correlated. Reliability testing and factor analysis revealed that both scores can be regarded as monocomponent. Categorizing patients according to the European League Against Rheumatism response criteria (EULARC) or the SDAI revealed statistically significant differences between the 2 scales (P < 0.0001).
CONCLUSION: SDAI values are considerably shifted to the left compared with DAS28 levels. Internal consistency and reliability of both scores are comparable. For the differences in disease activity categorizing due to the SDAI compared with the EULARC, a major limitation of the application of this newly developed disease activity score is given, unless these incongruencies can be cleared.

Entities:  

Mesh:

Year:  2005        PMID: 15696565     DOI: 10.1002/art.20923

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  15 in total

1.  Carotid artery stiffness in Behçet's disease.

Authors:  Servet Yolbaş; Nevzat Gözel; Mustafa Necati Dağlı; Süleyman Serdar Koca; Emir Dönder
Journal:  Eur J Rheumatol       Date:  2017-06-01

2.  Effectiveness of anti-tumor necrosis factor agents in the treatment of rheumatoid arthritis: observational study.

Authors:  Anna D'Souza; Brian L Meissner; Boxiong Tang; R Scott McKenzie; Catherine T Piech
Journal:  Am Health Drug Benefits       Date:  2010-07

3.  Visfatin levels and intima-media thicknesses in rheumatic diseases.

Authors:  Metin Ozgen; Suleyman Serdar Koca; Kader Aksoy; Necati Dagli; Bilal Ustundag; Ahmet Isik
Journal:  Clin Rheumatol       Date:  2010-12-17       Impact factor: 2.980

4.  The functional class evaluated in rheumatoid arthritis is associated with soluble TGF-β1 serum levels but not with G915C (Arg25Pro) TGF-β1 polymorphism.

Authors:  José Francisco Muñoz-Valle; Nora Magdalena Torres-Carrillo; Iris Paola Guzmán-Guzmán; Norma Torres-Carrillo; Sandra Luz Ruiz-Quezada; Claudia Azucena Palafox-Sánchez; Héctor Rangel-Villalobos; María Guadalupe Ramírez-Dueñas; Isela Parra-Rojas; Mary Fafutis-Morris; Blanca Estela Bastidas-Ramírez; Ana Laura Pereira-Suárez
Journal:  Rheumatol Int       Date:  2010-11-27       Impact factor: 2.631

5.  Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis.

Authors:  Norma Torres-Carrillo; Nora Magdalena Torres-Carrillo; Gloria Esther Martínez-Bonilla; Mónica Vázquez-Del Mercado; Claudia Azucena Palafox-Sánchez; Edith Oregón-Romero; Ana Guilaisne Bernard-Medina; Héctor Rangel-Villalobos; José Francisco Muñoz-Valle
Journal:  Clin Exp Med       Date:  2009-02-24       Impact factor: 3.984

6.  Calprotectin in rheumatoid arthritis : association with disease activity in a cross-sectional and a longitudinal cohort.

Authors:  Miriam García-Arias; Dora Pascual-Salcedo; Susana Ramiro; Marie-Eve Ueberschlag; Thomas M Jermann; Carlos Cara; Emilio Martín-Mola; Alejandro Balsa
Journal:  Mol Diagn Ther       Date:  2013-02       Impact factor: 4.074

7.  Ghrelin and obestatin levels in rheumatoid arthritis.

Authors:  Suleyman Serdar Koca; Metin Ozgen; Suleyman Aydin; Sait Dag; Bahri Evren; Ahmet Isik
Journal:  Inflammation       Date:  2008-10       Impact factor: 4.092

8.  Serum pro-hepcidin levels in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Suleyman Serdar Koca; Ahmet Isik; Bilal Ustundag; Kerem Metin; Kader Aksoy
Journal:  Inflammation       Date:  2008-02-16       Impact factor: 4.092

9.  A comparative evaluation of health related quality of life and depression in patients with fibromyalgia syndrome and rheumatoid arthritis.

Authors:  Berna Tander; Kivanc Cengiz; Gamze Alayli; Ilker Ilhanli; Sevgi Canbaz; Ferhan Canturk
Journal:  Rheumatol Int       Date:  2008-03-04       Impact factor: 2.631

10.  The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project.

Authors:  Burkhard F Leeb; Elke Böttcher; Hans-Peter Brezinschek; Christoph Czerwenka; Manfred Herold; Hans Hitzelhammer; Franz Mayrhofer; Rudolf Puchner; Franz Rainer; Bernhard Rintelen; Michael Schirmer; Ulrike Stuby; Hans Bröll
Journal:  Clin Rheumatol       Date:  2009-11-11       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.